Earnings Feed
Start Free
Home/Filings/4/0001209191-23-036748
4//SEC Filing

King Rachel K. 4

Accession 0001209191-23-036748

CIK 0001000694other
View on SEC.govCompany Profile

Filed

Jun 12, 8:00 PM ET

Accepted

Jun 13, 4:46 PM ET

Size

13.8 KB

Accession

0001209191-23-036748

Insider Transaction Report

Form 4
Period: 2023-06-10
NOVAVAX INCNVAX
King Rachel K.
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2023-06-10+3,100→ 10,050 total
  • Award

    Stock Option (Right to Buy)

    2023-06-12+7,710→ 7,710 total
    Exercise: $7.78From: 2024-06-12Exp: 2033-06-12→ Common Stock (7,710 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-10−3,100→ 0 total
    → Common Stock (3,100 underlying)
  • Award

    Restricted Stock Units

    2023-06-12+6,670→ 6,670 total
    → Common Stock (6,670 underlying)
Holdings

  • Common Stock

    (indirect: See Footnote)
    1,100

  • Common Stock

    (indirect: See Footnote)
    1,100
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
  • [F2]Represents shares attributable to the Reporting Person as indirect holdings held in a trust for the benefit of the Reporting Person's child.
  • [F3]One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), vested on the first anniversary of the June 10, 2022 grant date subject to continued service on the Company's Board of Directors through the vesting date.
  • [F4]One hundred percent (100%) of the shares subject to this option grant under the Plan will vest one (1) year from the June 12, 2023 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
  • [F5]One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.

Documents

1 file

Issuer

NOVAVAX INC

CIK 0001000694

→
Entity typeother

Related Parties

1
  • filerCIK 0001589712

Filing Metadata

Form type
4
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:46 PM ET
Size
13.8 KB
View on SEC.gov